ILMN
Diagnostics & Research · Healthcare
Chairman, Board Member
2023-06-01–present
Chairman
Illumina, Inc. (ILMN)Board Member
Illumina, Inc. (ILMN)Equibles does not estimate personal net worth.
Get an email with a short summary when Illumina, Inc. publishes a filing, an earnings call transcript or a press release.
Get ILMN alertsStephen P. MacMillan is recorded as Chairman and Board Member at Illumina, Inc. (ILMN) since June 1, 2023. HOLOGIC INC reported in an 8-K filed April 6, 2026 that Stephen P. MacMillan retired as Chairman of the Board of Directors. HOLOGIC INC reported in an 8-K filed April 6, 2026 that Stephen P. MacMillan retired as President and Chief Executive Officer. Illumina, Inc. reported in an 8-K filed March 25, 2025 that Stephen P. MacMillan resigned as director, effective March 28, 2025. Equibles holds 5 filed executive changes naming Stephen P. MacMillan; each is listed under recent activity with its source filing. Illumina, Inc. is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at Illumina, Inc. includes Jay T. Flatley (Chairman), John W. Thompson (Chairman), Scott Gottlieb (Chairman and Board Member) and 7 others.
“On April 6, 2026, Stephen P. MacMillan informed the Board of Directors of Hologic, Inc. (the "Company") of his retirement as President and Chief Executive Officer and as Chairman of the Board of Directors of the Company, contingent upon, and effective as of immediately after, the closing of the acquisition of the Company by affiliates of funds managed by Blackstone Inc. and TPG Global, LLC pursuant to the Agreement and Plan of Merger, dated October 21, 2025, by and among the Company, Hopper Parent Inc. and Hopper Merger Sub Inc (the "Merger").”
“On April 6, 2026, Stephen P. MacMillan informed the Board of Directors of Hologic, Inc. (the "Company") of his retirement as President and Chief Executive Officer and as Chairman of the Board of Directors of the Company, contingent upon, and effective as of immediately after, the closing of the acquisition of the Company by affiliates of funds managed by Blackstone Inc. and TPG Global, LLC pursuant to the Agreement and Plan of Merger, dated October 21, 2025, by and among the Company, Hopper Parent Inc. and Hopper Merger Sub Inc (the "Merger").”
2023-06-01–present
2023-06-01–present
2023-06-01–2025-03-28
ILMN
Diagnostics & Research · Healthcare
Chairman, Board Member
2023-06-01–present